OBI Financial Statements From 2010 to 2024
| 4174 Stock | TWD 60.80 1.00 1.62% |
Check OBI Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OBI Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . OBI financial statements analysis is a perfect complement when working with OBI Pharma Valuation or Volatility modules.
OBI |
OBI Pharma Company Shares Outstanding Analysis
OBI Pharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current OBI Pharma Shares Outstanding | 228.95 M |
Most of OBI Pharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OBI Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, OBI Pharma has 228.95 M of shares currently outstending. This is 26.82% higher than that of the Healthcare sector and 114.26% higher than that of the Biotechnology industry. The shares outstanding for all Taiwan stocks is 59.96% higher than that of the company.
OBI Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OBI Pharma's current stock value. Our valuation model uses many indicators to compare OBI Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OBI Pharma competition to find correlations between indicators driving OBI Pharma's intrinsic value. More Info.OBI Pharma is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OBI Pharma's earnings, one of the primary drivers of an investment's value.About OBI Pharma Financial Statements
OBI Pharma investors use historical fundamental indicators, such as OBI Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OBI Pharma. Please read more on our technical analysis and fundamental analysis pages.
OBI Pharma, Inc., a bio-pharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. The company was founded in 2002 and is based in Taipei, Taiwan. OBI PHARMA operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.
Pair Trading with OBI Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OBI Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OBI Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with OBI Stock
Moving against OBI Stock
| 0.73 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.73 | 0057 | Fubon MSCI Taiwan | PairCorr |
| 0.72 | 1449 | Chia Her Industrial Split | PairCorr |
| 0.69 | 4162 | PharmaEngine | PairCorr |
| 0.62 | 2609 | Yang Ming Marine | PairCorr |
The ability to find closely correlated positions to OBI Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OBI Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OBI Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OBI Pharma to buy it.
The correlation of OBI Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OBI Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OBI Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OBI Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OBI Stock Analysis
When running OBI Pharma's price analysis, check to measure OBI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OBI Pharma is operating at the current time. Most of OBI Pharma's value examination focuses on studying past and present price action to predict the probability of OBI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OBI Pharma's price. Additionally, you may evaluate how the addition of OBI Pharma to your portfolios can decrease your overall portfolio volatility.